Editor’s Note Archive

Last June, a perceptions poll of 370 gender specialists conducted by TrustLaw, a legal news service run by Thomson Reuters…

The new rules on compensation for death/ injury during clinical trials once again highlight the tough choices faced by our policy…

'The Fourth Estate: A Watchdog or A Hound?' That was the topic of the 17th Lalit Doshi Memorial Lecture, given by Shekhar Gupta,…

Clinical trials and research in India seems to be in danger of getting mired in the quicksand of evolving regulation. And going by…

With 2013 all set to be a watershed year in the life sciences sector in India, we present some ‘Predictions from Pharma Pundits’…

Piramal Enterprises' second buy in the pharmaceutical analytics sector, the UK-based Abacus International, is an indicator of the…

The pharmaceutical industry used to be considered recession proof as compared to other sectors, but that myth has been roundly…

In my editorial dated June 29, I had asked, ‘Obamacare passed, but will Obama?’ (bit.ly/UmOwq7). 

In the run up to our 18th Anniversary issue, we ran a poll on our website, with the motion of the house being: The Indian patent…

With the Supreme Court closely tracking policy makers, both on the drug pricing and clinical trials front, will the pharmaceutical…

Under threat of an interim order from the Supreme Court, the Group of Ministers (GoM) tasked with framing India's drug pricing…

On a day that saw one vaccine major announce a major collaboration in the generic and branded pharma space, another player…

The debate on patents vs patients remains on the boil, with the Bayer/ Nexavar and Novartis/ Gleevec cases keeping the issue live.…

With the London 2012 Olympics just behind us, we don't need to be reminded that being first counts.

Policy makers in India need to adapt fast to new realities and move forward like other global regulators

The release of guidelines for biosimilar drugs in India reportedly created a buzz at last month’s BIO meet at Boston. The 52-page…

In a landmark judgement, 'Obamacare', President Barack Obama's reform of the US healthcare system, won by a close 5-4 vote in the…

Tuberculosis, once known as a poor man’s illness, today shows no class discrimination. Bollywood super stars, top performing super…

First the good news. The BSE Healthcare Index has outperformed the overall Sensex in the last two years. Indian pharmaceutical…

At the recently concluded World Health Assembly in Geneva, one of the hotly debated topics was the adoption of a global Convention…